- About Us
Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) is a drug development collaboration company that uses innovative clinical development design to accelerate and increase value of partnered drug programs by advancing them through to Phase III in a cost-efficient manner.
Development programs are designed and driven by a leadership team that collectively has more than 75 years of experience in all areas of drug development. The Furiex model has proven success, with two compounds in Phase III development, one that is Phase III ready, and two products on the market.
Furiex Pharmaceuticals has a strong, diversified product portfolio and pipeline with multiple therapeutic candidates including late-stage assets.
Our strategy is to leverage our drug development experience to in-license, develop and commercialize novel early-stage drug candidates that address medical conditions with significant unmet medical need. The key elements of our strategy include: